Clinical Effect of Phenytoin Mucoadhesive Paste on Wound Healing After Oral Biopsy

NCT ID: NCT01680042

Last Updated: 2012-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

several studies have investigated healing effect of phenytoin.In this study we investigate healing effect of phenytoin mucoadhesive paste comparing to the usual mucoadhesive paste after oral biopsy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wound Healing Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

inflammatory halo VAS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

phenytoin paste

this group receives phenytoin paste after oral biopsy

Group Type ACTIVE_COMPARATOR

Phenytoin paste

Intervention Type DRUG

usual mucoadhesive paste

this group receives the usual mucoadhesive paste without phenytoin after oral biopsy

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phenytoin paste

Intervention Type DRUG

Placebo

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients undergone oral biopsy

Exclusion Criteria

* systemic disease
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shahid Beheshti University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

somayeh alirezaei

resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shaheed Beheshti University

Tehran, , Iran

Site Status RECRUITING

Shahid Beheshti Medical University

Tehran, , Iran

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Iran

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

somayeh alirezaei, DDS

Role: CONTACT

Phone: 09123705943

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

somayeh alirezaei, resident

Role: primary

somayeh alirezaei, DDS

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Merck-023

Identifier Type: -

Identifier Source: org_study_id